chevron_leftBack
As of 13 June 2026, CKD Bio Corp. has a market cap of $70.81M USD, ranking #28033 globally and #1465 in South Korea.
It ranks #2530 in the Healthcare sector, and #908 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$70.81MUSD
107.69B KRW
Revenue (TTM)
$105.16MUSD
159.93B KRW
EBITDA (TTM)
-$4.85MUSD
-7.4B KRW
Net Income (TTM)
-$15.21MUSD
-23.13B KRW
EBITDA Margin
-4.6%
Profit Margin
-14%
PS Ratio
0.7
PB Ratio
0.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Wan-Kap Park
open_in_new
Employees
519
Founded
1941
Website
ckdbio.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.6% | -0.6% | 1.1% | -9.7% | -10% | -14% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
063160
(주)종근당바이오
ISIN: KR7063160006
Shares Out.:
Shares Outstanding:
5.486M1
Shares Float:
3.338M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
19,510 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About CKD Bio Corp.
CKD Bio Corp. engages in the manufacturing and sale of pharmaceutical products in South Korea, Europe, Asia, the Middle East, and internationally. The company is also involved in real estate leasing and related ancillary; bio, cosmetics, and health functional food; property management; advertising communication; consulting, construction, and maintenance of corporate IT systems business. It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 0126Z0
|
$9.15B
13K%
13.91T KRW
|
-
|
|
KRX: 000250
|
$6.77B
9K%
10.3T KRW
|
1958.1
|
|
KRX: 326030
|
$5.24B
7K%
7.97T KRW
|
29.9
|
|
KRX: 298380
|
$4.96B
7K%
7.55T KRW
|
-
|
|
KRX: 000100
|
$4.55B
6K%
6.92T KRW
|
35.9
|
|
KRX: 141080
|
$4.44B
6K%
6.76T KRW
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
1M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
773K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
509K%
|
97.4
|
|
SIX: RO
|
$321.52B
454K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
408K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
388K%
218.9B CHF
|
20.5
|
chevron_leftBack